

Instance: composition-en-0b425a6e45767f61f6d3b4247eda39d0
InstanceOf: CompositionUvEpi
Title: "Composition for bimervax Package Leaflet"
Description:  "Composition for bimervax Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mock)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - bimervax"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What is in this leaflet</p>
<ol>
<li>What BIMERVAX is and what it is used for  </li>
<li>What you need to know before you receive  BIMERVAX    </li>
<li>How BIMERVAX is given </li>
<li>Possible side effects  </li>
<li>How to store BIMERVAX    </li>
<li>Contents of the pack and other information </li>
</ol>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What bimervax is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What bimervax is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>BIMERVAX is a vaccine used to prevent COVID-19 caused by the SARS-CoV-2 virus. </p>
<p>BIMERVAX is given to individuals 16 years of age and older who have previously received a mRNA 
COVID-19 vaccine. </p>
<p>The vaccine stimulates the immune system (the body s natural defences) to produce specific 
antibodies that work against the virus, giving protection against COVID-19. None of the ingredients in 
this vaccine can cause COVID-19. </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take bimervax"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take bimervax"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>BIMERVAX should not be given 
- if you are allergic to the active substance or any of the other ingredients of this medicine (listed 
in section 6). </p>
<p>Warnings and precautions<br />
Talk to your doctor, pharmacist or nurse before receiving BIMERVAX if: 
* you have ever had a severe or life-threatening allergic reaction after receiving any other vaccine 
injection; 
* you have ever fainted following any needle injection; 
* you have a high temperature (over 38  C) or severe infection. However, you can have your 
vaccination if you have a mild fever or upper airway infection like a cold; 
* you have bleeding problems, you bruise easily or you use a medicine to prevent blood clots 
(anticoagulant medicine); 
* your immune system does not work properly (immunodeficiency) or you are taking medicines 
that weaken the immune system (such as high-dose corticosteroids, immunosuppressants, or 
cancer medicines). </p>
<p>If any of the above apply to you (or you are not sure), talk to your doctor, pharmacist, or nurse before 
you are given BIMERVAX. </p>
<p>As with any vaccine, BIMERVAX may not fully protect all those who receive it, and it is not known 
how long you will be protected. </p>
<p>Children and adolescents 
BIMERVAX is not recommended for children aged below 16 years. Currently, there is no information 
available on the use of BIMERVAX in children younger than 16 years of age. </p>
<p>Other medicines and BIMERVAX 
Tell your doctor, pharmacist, or nurse if you are taking, have recently taken, or might take any other 
medicines or vaccines. </p>
<p>Pregnancy and breastfeeding<br />
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask 
your doctor, pharmacist, or nurse for advice before you receive this vaccine. </p>
<p>Driving and using machines 
Some of the side effects of BIMERVAX listed in section 4 (Possible side effects) may temporarily 
reduce your ability to drive and use machines. Wait until any effects of the vaccine have worn off 
before you drive or use machines. </p>
<p>BIMERVAX contains sodium and potassium 
This vaccine contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially 
 sodium-free .  </p>
<p>This vaccine contains less than 1 mmol potassium (39 milligrams) per 0.5 mL dose, that is to say, 
essentially  potassium-free . </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take bimervax"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take bimervax"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>BIMERVAX will be given to you as 0.5 mL injection into a muscle of your upper arm.  </p>
<p>It is recommended that you receive BIMERVAX as a single dose at least 6 months after a previous 
vaccination series with mRNA COVID-19 vaccine. </p>
<p>After the injection, your doctor, pharmacist or nurse will watch over you for around 15 minutes to 
monitor for signs of an allergic reaction. </p>
<p>If you have any further questions on the use of BIMERVAX, ask your doctor, pharmacist or nurse. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Like all medicines, this vaccine can cause side effects, although not everybody gets them.  </p>
<p>Most of the side effects occur within 3 days of getting the vaccine and go away within a few days of 
appearing. If symptoms persist, contact your doctor, pharmacist or nurse. </p>
<p>Get urgent medical attention if you get symptoms of a severe allergic reaction shortly after 
vaccination. Such symptoms may include: 
* feeling faint or light-headed 
* changes in your heartbeat 
* shortness of breath 
* wheezing 
* swelling of your lips, face, or throat<br />
* itchy swelling under the skin (hives) or rash 
* feeling sick (nausea) or vomiting 
* stomach pain. </p>
<p>The following side effects may occur with BIMERVAX:  </p>
<p>Very common (may affect more than 1 in 10 people)<br />
<em> headache<br />
</em> pain where the injection is given<br />
<em> feeling very tired (fatigue)<br />
</em> muscle pain </p>
<p>Common (may affect up to 1 in 10 people)<br />
<em> redness, swelling or tenderness where the injection is given<br />
</em> feeling sick (nausea) or getting sick (vomiting) 
* diarrhoea 
* fever<br />
<em> enlarged lymph nodes<br />
</em> axillary pain </p>
<p>Uncommon (may affect up to 1 in 100 people):<br />
* chills or feeling feverish 
* insomnia 
* dizziness 
* itching where the injection is given 
* hipersensitivity where the injection is given 
* joint pain 
* feeling weak or lack of energy 
* feeling sleepy 
* abdominal pain 
* itchy skin 
* pain when swallowing 
* generally feeling unwell </p>
<p>Rare (may affect up to 1 in 1 000 people):<br />
<em> Cold sweating 
* unusual feeling in the skin, such as tingling or a crawling feeling (paraesthesia) 
* decreased feeling of sensitivity, especially in the skin (hypoaesthesia)<br />
</em> allergic reactions such as hives, rash or itching 
* Back pain 
* Bruise where the injection is given </p>
<p>Not known (cannot be estimated from available data, based on a single case during clinical trials):<br />
* Inflammation of the lining outside the heart (pericarditis), which can result in breathless, 
palpitations or chest pain </p>
<p>Reporting of side effects 
If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side 
effects not listed in this leaflet. You can also report side effects directly via the national reporting 
system listed in Appendix V and include batch/Lot number if available. By reporting side effects, you 
can help provide more information on the safety of this vaccine. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store bimervax"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store bimervax"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Keep this medicine out of the sight and reach of children. 
Your doctor, pharmacist, or nurse is responsible for storing this vaccine and disposing of any unused 
product correctly. The following information about storage, expiry, use and handling as well as 
disposal is intended for healthcare professionals. 
Do not use this vaccine after the expiry date which is stated on the label after EXP. 
Store in a refrigerator (2  C   8  C). Do not freeze. Keep vials in outer carton in order to protect from 
light.<br />
After first puncture, store at 2  C   8  C, use within 6 hours. 
Information on handling are described in the section intended for healthcare professionals at the end of 
the package leaflet. 
Any unused medicinal product or waste material should be disposed of in accordance with local 
requirements.  </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <h2>What BIMERVAX contains</h2>
<h2>One dose (0.5 mL) contains 40 micrograms of selvacovatein adjuvanted with SQBA.</h2>
<p>Selvacovatein is SARS-CoV-2 virus recombinant spike (S) protein RBD 
fusion heterodimer B.1.351 and B.1.1.7 strains) produced by recombinant DNA 
technology.
-
SQBA is included in this vaccine as an adjuvant to accelerate and improve the protective 
effects of the vaccine. SQBA contains per 0.5 mL dose: squalene (9.75 mg), polysorbate (1.18 mg), sorbitan trioleate (1.18 mg), sodium citrate (0.66 mg), citric acid (0.04 mg) and 
water for injections.
-
The other ingredients (excipients) are: disodium phosphate dodecahydrate, potassium 
dihydrogen phosphate, sodium chloride, potassium chloride and water for injections. 
BIMERVAX contains potassium and sodium (see section 2).
What BIMERVAX looks like and contents of the pack 
The vaccine is a white homogeneous emulsion for injection. 
5 mL of emulsion is provided in a vial with a rubber stopper and a plastic flip-off top. 
Each vial contains 10 doses of 0.5 mL.<br />
Pack size: 10 multidose vials. 
Marketing Authorisation Holder  </p>
<p>Hipra Human Health, S.L.U. 
Avda. la Selva, 17170 Amer (Girona) 
SPAIN </p>
<p>Manufacturer </p>
<p>Laboratorios Hipra, S.A. 
Avda. la Selva, 17170 Amer (Girona) 
SPAIN </p>
<p>This leaflet was last revised in  </p>
<p>Other sources of information  </p>
<p>Detailed information on this medicine is available on the European Medicines Agency web site: </p>         </div>"""      





                      
Instance: bundlepackageleaflet-en-0b425a6e45767f61f6d3b4247eda39d0
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for bimervax Package Leaflet for language en"
Description: "ePI document Bundle for bimervax Package Leaflet for language en"
Usage: #example




* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #en

// Composition
* entry[0].fullUrl = "Composition/composition-en-0b425a6e45767f61f6d3b4247eda39d0"
* entry[0].resource = composition-en-0b425a6e45767f61f6d3b4247eda39d0
                      
                      